{"name":"Greater Houston Retina Research","slug":"greater-houston-retina-research","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Ophthalmology","slug":"ophthalmology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Macugen","genericName":"Macugen","slug":"macugen","indication":"Exudative age-related macular degeneration","status":"discontinued"}]},{"name":"Metabolic","slug":"metabolic","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"Ranibizumab (Lucentis)","genericName":"Ranibizumab (Lucentis)","slug":"ranibizumab-lucentis","indication":"Neovascular (wet) age-related macular degeneration","status":"marketed"}]}],"pipeline":[{"name":"Macugen","genericName":"Macugen","slug":"macugen","phase":"discontinued","mechanism":"Vascular endothelial growth factor A","indications":["Exudative age-related macular degeneration"],"catalyst":""},{"name":"Ranibizumab (Lucentis)","genericName":"Ranibizumab (Lucentis)","slug":"ranibizumab-lucentis","phase":"marketed","mechanism":"Ranibizumab is a monoclonal antibody fragment that binds and inhibits vascular endothelial growth factor A (VEGF-A), reducing abnormal blood vessel growth and leakage in the eye.","indications":["Neovascular (wet) age-related macular degeneration","Macular edema following retinal vein occlusion","Diabetic macular edema","Diabetic retinopathy","Myopic choroidal neovascularization"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMif0FVX3lxTE9GWlNkdVZvU0FYRDIzUTlQSEhZazExRWloMHpYVzFBTXNtZm93Qkh0OHFfajJtNDdYTFhBOUtVV3Y4cFVYSXBHbFBYbloyNHlyVHhzRjZoVXkxanJuNVFOWDVwazhYUXlhTmJZcnVyMkRsNDE3MlBnZ1EwU05OQkE?oc=5","date":"2025-12-26","type":"pipeline","source":"InnovationMap","summary":"Innovative Houston research leads our top health tech news of 2025 - InnovationMap","headline":"Innovative Houston research leads our top health tech news of 2025","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi-AFBVV95cUxOdUZNUWtTaGpGTl96TE45T3VjUHFoS2I3eXczSkpEbzdiYTVDWE1PcDdQel9tZFJ5NVhMTHU5ZmJDemhydU1ZYmxUbkVUbC0zaDBSaWFKTmFJOWtrUFZKeU80QklZMzVTNFJCb2pXQWlVT1JmQk92LTF4a2djYVEzd1puYXY5RWdjQmhVYmI5OUlWejRrcHVXdDBuZ3lISlplLTNyTEl1UndCbUxybTl1V1FZejkxQnlxclBoWVotaFA0dUhxdWtacDYyRGxDczNNWUtuNFZJbUpXQkhNeVl4LURROGotR2hXYmZIUzdmSk92TTVxTDl6NQ?oc=5","date":"2025-03-06","type":"regulatory","source":"BioSpace","summary":"Neurotech’s ENCELTO™ (revakinagene taroretcel-lwey) Approved by the FDA for the Treatment of Macular Telangiectasia Type 2 (MacTel) - BioSpace","headline":"Neurotech’s ENCELTO™ (revakinagene taroretcel-lwey) Approved by the FDA for the Treatment of Macular Telangiectasia Type","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxQNjJLalRRRDNqRzJNV2ZHOUhRRE5yaXFaMXFIUVNIVWtNd1hBOG9vVUNhd1lrQjlLVkN3Z21xNmFOdl9VMldtdXJtUDY2NGhERk1mTkhEeW5YZERiMk9BS2VFdXhyRDFlTm9YTTZNSEFxLXk1WFRqNEhSNWhPQXJzWGo4aGRzd3hzVlBxS3JMajFPMU01Q2NDOVBkNFhwMjlhTXVfZUJ3?oc=5","date":"2024-01-19","type":"pipeline","source":"Eyes On Eyecare","summary":"iuvo BioSciences purchases Promedica International - Eyes On Eyecare","headline":"iuvo BioSciences purchases Promedica International","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiXEFVX3lxTE94WVFnY0p4WjVTcDB1Wjgya2Z2SWN5R00xY1g1TDBuUDNyWExXbjBRVU5qSGJMdDExSGJyY3ZBcHBoOG9iUS1mRjZfVjhKX2ZoTVkyZWIzZWJVRG1f?oc=5","date":"2016-10-29","type":"pipeline","source":"American Academy of Ophthalmology","summary":"The Aging Patient - American Academy of Ophthalmology","headline":"The Aging Patient","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"discontinued":1,"marketed":1},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}